{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:31:31Z","timestamp":1783765891055,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to compare the diagnostic validity of biparametric magnetic resonance imaging (bpMRI) with that of multiparametric MRI (mpMRI) based on the Vesicle Imaging-Reporting and Data System (VI-RADS) in predicting muscle invasion by bladder cancer (BCa). We retrospectively examined 357 patients with an initial diagnosis of BCa who underwent preoperative MRI; 257 and 100 patients underwent mpMRI and bpMRI, respectively. Two urogenital radiologists evaluated all bpMRI and mpMRI scans using VI-RADS, and the diagnostic validity of VI-RADS for predicting muscle invasion by BCa was analyzed based on histopathology of the first and\/or second transurethral resection of bladder tumors and radical cystectomy. Receiver operating characteristic (ROC) curves were plotted with the calculation of area under the curves (AUCs), and the level of significance was P\u2009&lt;\u20090.05. Both groups showed optimal performance with a VI-RADS score\u2009\u2265\u20093. BpMRI showed comparable diagnostic performance to mpMRI (reader 1: AUC, 0.903 [0.827\u20130.954] vs. 0.935 [0.884\u20130.968], p\u2009=\u20090.510; and reader 2: AUC, 0.901 [0.814\u20130.945] vs. 0.915 [0.874\u20130.946]; p\u2009=\u20090.655). The inter-reader agreement between both readers was excellent (Cohen\u2019s kappa value\u2009=\u20090.942 and 0.905 for bpMRI and mpMRI, respectively). This comparative study suggests that bpMRI has comparable diagnostic performance to mpMRI and may be an alternative option to predict muscle invasion by BCa.<\/jats:p>","DOI":"10.1038\/s41598-022-19273-7","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T19:11:03Z","timestamp":1669835463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS"],"prefix":"10.1038","volume":"12","author":[{"given":"Tae Il","family":"Noh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sung","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Gu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deuk Jae","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Choon","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Ho","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"19273_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"19273_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.eururo.2017.04.015","volume":"72","author":"V Soukup","year":"2017","unstructured":"Soukup, V. et al. Prognostic performance and reproducibility of the 1973 and 2004\/2016 World Health Organization Grading Classification Systems in non-muscle-invasive bladder cancer: A European Association of Urology non-muscle invasive bladder cancer guidelines panel systematic review. Eur. Urol. 72, 801\u2013813 (2017).","journal-title":"Eur. Urol."},{"key":"19273_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0022-5347(05)67975-X","volume":"163","author":"F Mill\u00e1n-Rodr\u00edguez","year":"2000","unstructured":"Mill\u00e1n-Rodr\u00edguez, F., Ch\u00e9chile-Toniolo, G., Salvador-Bayarri, J., Palou, J. & Vicente-Rodr\u00edguez, J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J. Urol. 163, 73\u201378 (2000).","journal-title":"J. Urol."},{"key":"19273_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","volume":"198","author":"SS Chang","year":"2017","unstructured":"Chang, S. S. et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline. J. Urol. 198, 552\u2013559 (2017).","journal-title":"J. Urol."},{"key":"19273_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","volume":"76","author":"M Babjuk","year":"2019","unstructured":"Babjuk, M. et al. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)\u20142019 update. Eur. Urol. 76, 639\u2013657 (2019).","journal-title":"Eur. Urol."},{"key":"19273_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes, J. A. et al. European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines. Eur. Urol. 79, 82\u2013104 (2021).","journal-title":"Eur. Urol."},{"key":"19273_CR7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","volume":"73","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch, M. G. K. et al. Repeat transurethral resection in non-muscle-invasive bladder cancer: A systematic review. Eur. Urol. 73, 925\u2013933 (2018).","journal-title":"Eur. Urol."},{"key":"19273_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco, V. et al. Multiparametric magnetic resonance imaging for bladder cancer: Development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur. Urol. 74, 294\u2013306 (2018).","journal-title":"Eur. Urol."},{"key":"19273_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","volume":"3","author":"S Woo","year":"2020","unstructured":"Woo, S. et al. Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: A systematic review and meta-analysis. Eur. Urol. Oncol. 3, 306\u2013315 (2020).","journal-title":"Eur. Urol. Oncol."},{"key":"19273_CR10","doi-asserted-by":"crossref","unstructured":"Jazayeri, S. B. et al. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis. Urol. Oncol. (2021).","DOI":"10.1016\/j.urolonc.2021.11.008"},{"key":"19273_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00261-021-03383-3","volume":"47","author":"S Aslan","year":"2022","unstructured":"Aslan, S., Cakir, I. M., Oguz, U., Bekci, T. & Demirelli, E. Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion?. Abdom. Radiol. (NY) 47, 771\u2013780 (2022).","journal-title":"Abdom. Radiol. (NY)"},{"key":"19273_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109829","volume":"142","author":"J Gmeiner","year":"2021","unstructured":"Gmeiner, J., Garstka, N., Helbich, T. H., Shariat, S. F. & Baltzer, P. A. Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?. Eur. J. Radiol. 142, 109829 (2021).","journal-title":"Eur. J. Radiol."},{"key":"19273_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110282","volume":"151","author":"ASF Elshetry","year":"2022","unstructured":"Elshetry, A. S. F., El-Fawakry, R. M., Hamed, E. M., Metwally, M. I. & Zaid, N. A. Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer. Eur. J. Radiol. 151, 110282 (2022).","journal-title":"Eur. J. Radiol."},{"key":"19273_CR14","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1007\/s00330-020-07473-6","volume":"31","author":"A DelliPizzi","year":"2021","unstructured":"DelliPizzi, A. et al. Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach. Eur. Radiol. 31, 3874\u20133883 (2021).","journal-title":"Eur. Radiol."},{"key":"19273_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/BLC-190267","volume":"6","author":"K Sakamoto","year":"2020","unstructured":"Sakamoto, K. et al. Detection of muscle-invasive bladder cancer on biparametric MRI using vesical imaging-reporting and data system and apparent diffusion coefficient values (VI-RADS\/ADC). Bladder Cancer 6, 161\u2013169 (2020).","journal-title":"Bladder Cancer"},{"key":"19273_CR16","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.21037\/tau-19-671","volume":"9","author":"KC Sim","year":"2020","unstructured":"Sim, K. C. & Sung, D. J. Role of magnetic resonance imaging in tumor staging and follow-up for bladder cancer. Transl. Androl. Urol. 9, 2890\u20132907 (2020).","journal-title":"Transl. Androl. Urol."},{"key":"19273_CR17","volume-title":"TNM Classification of Malignant Tumours","author":"LH Sobin","year":"2011","unstructured":"Sobin, L. H., Gospodarowicz, M. K. & Wittekind, C. TNM Classification of Malignant Tumours (Wiley, 2011)."},{"key":"19273_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12957-018-1310-0","volume":"16","author":"P Zapa\u0142a","year":"2018","unstructured":"Zapa\u0142a, P. et al. Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer. World J. Surg. Oncol. 16, 6 (2018).","journal-title":"World J. Surg. Oncol."},{"key":"19273_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.rx.2017.04.003","volume":"59","author":"D Ib\u00e1\u00f1ez Mu\u00f1oz","year":"2017","unstructured":"Ib\u00e1\u00f1ez Mu\u00f1oz, D. et al. Virtual cystoscopy, computed tomography urography and optical cystoscopy for the detection and follow-up for bladder cancer. Radiologia 59, 422\u2013430 (2017).","journal-title":"Radiologia"},{"key":"19273_CR20","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1007\/s00330-019-06117-8","volume":"29","author":"G Barchetti","year":"2019","unstructured":"Barchetti, G. et al. Multiparametric MRI of the bladder: Inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center. Eur. Radiol. 29, 5498\u20135506 (2019).","journal-title":"Eur. Radiol."},{"key":"19273_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.eururo.2019.03.012","volume":"76","author":"Y Ueno","year":"2019","unstructured":"Ueno, Y. et al. Diagnostic accuracy and interobserver agreement for the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer: A multireader validation study. Eur. Urol. 76, 54\u201356 (2019).","journal-title":"Eur. Urol."},{"key":"19273_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1148\/radiol.2019182506","volume":"291","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Multiparametric MRI for bladder cancer: Validation of VI-RADS for the detection of detrusor muscle invasion. Radiology 291, 668\u2013674 (2019).","journal-title":"Radiology"},{"key":"19273_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.eururo.2019.09.029","volume":"77","author":"F Del Giudice","year":"2020","unstructured":"Del Giudice, F. et al. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non-muscle-invasive bladder cancer patients candidate for repeated transurethral resection. Eur. Urol. 77, 101\u2013109 (2020).","journal-title":"Eur. Urol."},{"key":"19273_CR24","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00261-021-03365-5","volume":"47","author":"M Pecoraro","year":"2022","unstructured":"Pecoraro, M. et al. Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: Preliminary report. Abdom. Radiol. (NY) 47, 763\u2013770 (2022).","journal-title":"Abdom. Radiol. (NY)"},{"key":"19273_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.euo.2021.05.002","volume":"5","author":"R Contieri","year":"2022","unstructured":"Contieri, R. et al. Long-term follow-up and factors associated with active surveillance failure for patients with non-muscle-invasive bladder cancer: The Bladder Cancer Italian Active Surveillance (BIAS) experience. Eur. Urol. Oncol. 5, 251\u2013255 (2022).","journal-title":"Eur. Urol. Oncol."},{"key":"19273_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.832835","volume":"12","author":"V Fasulo","year":"2022","unstructured":"Fasulo, V. et al. Xpert bladder cancer monitor may avoid cystoscopies in patients under \u201cactive surveillance\u201d for recurrent bladder cancer (BIAS Project): Longitudinal cohort study. Front. Oncol. 12, 832835. https:\/\/doi.org\/10.3389\/fonc.2022.832835 (2022).","journal-title":"Front. Oncol."},{"key":"19273_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.eururo.2018.06.017","volume":"74","author":"HC Thoeny","year":"2018","unstructured":"Thoeny, H. C., Bellin, M. F., Comperat, E. M. & Thalmann, G. N. Vesical Imaging-Reporting and Data System (VI-RADS): Added value for management of bladder cancer patients?. Eur. Urol. 74, 307\u2013308 (2018).","journal-title":"Eur. Urol."},{"key":"19273_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MNH.0000000000000475","volume":"28","author":"K Leyba","year":"2019","unstructured":"Leyba, K. & Wagner, B. Gadolinium-based contrast agents: Why nephrologists need to be concerned. Curr. Opin. Nephrol. Hypertens. 28, 154\u2013162 (2019).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"19273_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1148\/rg.2020190110","volume":"40","author":"M Mathur","year":"2020","unstructured":"Mathur, M., Jones, J. R. & Weinreb, J. C. Gadolinium deposition and nephrogenic systemic fibrosis: A radiologist\u2019s primer. Radiographics 40, 153\u2013162 (2020).","journal-title":"Radiographics"},{"key":"19273_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/RMR.0000000000000109","volume":"25","author":"JR Costello","year":"2016","unstructured":"Costello, J. R., Kalb, B. & Martin, D. R. Incidence and risk factors for gadolinium-based contrast agent immediate reactions. Top. Magn. Reason. Imaging 25, 257\u2013263 (2016).","journal-title":"Top. Magn. Reason. Imaging"},{"key":"19273_CR31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.amjmed.2015.02.018","volume":"128","author":"TA Rose Jr","year":"2015","unstructured":"Rose, T. A. Jr. & Choi, J. W. Intravenous imaging contrast media complications: The basics that every clinician needs to know. Am. J. Med. 128, 943\u2013949 (2015).","journal-title":"Am. J. Med."},{"key":"19273_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.eururo.2019.03.044","volume":"77","author":"A Saita","year":"2020","unstructured":"Saita, A. et al. Assessing the feasibility and accuracy of high-resolution microultrasound imaging for bladder cancer detection and staging. Eur. Urol. 77, 727\u2013732 (2020).","journal-title":"Eur. Urol."},{"key":"19273_CR33","first-page":"1","volume":"2022","author":"P Diana","year":"2022","unstructured":"Diana, P. et al. Head-to-head comparison between high-resolution microultrasound imaging and multiparametric MRI in detecting and local staging of bladder cancer: The BUS-MISS protocol. Bladder Cancer 2022, 1\u20139 (2022).","journal-title":"Bladder Cancer"},{"key":"19273_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejrad.2018.01.028","volume":"101","author":"E Di Campli","year":"2018","unstructured":"Di Campli, E. et al. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience. Eur. J. Radiol. 101, 17\u201323 (2018).","journal-title":"Eur. J. Radiol."},{"key":"19273_CR35","doi-asserted-by":"publisher","first-page":"714","DOI":"10.4143\/crt.2019.716","volume":"52","author":"TI Noh","year":"2020","unstructured":"Noh, T. I. et al. Diagnostic accuracy and value of magnetic resonance imaging-ultrasound fusion transperineal targeted and template systematic prostate biopsy based on bi-parametric magnetic resonance imaging. Cancer Res. Treat. 52, 714\u2013721 (2020).","journal-title":"Cancer Res. Treat."},{"key":"19273_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-08696-5","author":"L Ye","year":"2022","unstructured":"Ye, L. et al. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: A systematic review and meta-analysis. Eur. Radiol. https:\/\/doi.org\/10.1007\/s00330-022-08696-5 (2022).","journal-title":"Eur. Radiol."},{"key":"19273_CR37","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1007\/s00330-017-4759-2","volume":"27","author":"M Lee","year":"2017","unstructured":"Lee, M. et al. Non-contrast magnetic resonance imaging for bladder cancer: Fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion. Eur. Radiol. 27, 3752\u20133758 (2017).","journal-title":"Eur. Radiol."},{"key":"19273_CR38","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2214\/AJR.16.17114","volume":"208","author":"CH Lee","year":"2017","unstructured":"Lee, C. H., Tan, C. H., Faria, S. C. & Kundra, V. Role of imaging in the local staging of urothelial carcinoma of the bladder. AJR Am. J. Roentgenol. 208, 1193\u20131205 (2017).","journal-title":"AJR Am. J. Roentgenol."},{"key":"19273_CR39","first-page":"Tc01","volume":"10","author":"E Rabie","year":"2016","unstructured":"Rabie, E., Faeghi, F., Izadpanahi, M. H. & Dayani, M. A. Role of dynamic contrast-enhanced magnetic resonance imaging in staging of bladder cancer. J. Clin. Diagn. Res. 10, Tc01\u2013Tc05 (2016).","journal-title":"J. Clin. Diagn. Res."},{"key":"19273_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cncr.23986","volume":"115","author":"E Scosyrev","year":"2009","unstructured":"Scosyrev, E., Noyes, K., Feng, C. & Messing, E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 115, 68\u201374 (2009).","journal-title":"Cancer"},{"key":"19273_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.ackd.2017.10.010","volume":"25","author":"ESV Torres da Costa","year":"2018","unstructured":"Torres da Costa, E. S. V., Costalonga, E. C., Coelho, F. O., Caires, R. A. & Burdmann, E. A. Assessment of kidney function in patients with cancer. Adv. Chronic Kidney Dis. 25, 49\u201356 (2018).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"19273_CR42","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1148\/radiol.2017162020","volume":"284","author":"BK Barth","year":"2017","unstructured":"Barth, B. K. et al. Detection of clinically significant prostate cancer: Short dual-pulse sequence versus standard multiparametric MR imaging\u2014A multireader study. Radiology 284, 725\u2013736 (2017).","journal-title":"Radiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19273-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T19:11:12Z","timestamp":1669835472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19273-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19273"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19273-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"21 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20689"}}